{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"}],"units":"Participants"}],"description":"Hospitalization related to COVID-19 was ascertained through electronic health record (EHR) data obtained with participant permission. COVID-19-related outcomes included COVID-19 infection and associated clinical events (e.g., hospitalization), as documented in the EHR.","groups":[{"description":"Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria.\n\nPatient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.","id":"OG000","title":"Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Among the enrolled participants, 79 consented to share their electronic health record (EHR) data. Participation in EHR data sharing was optional and not a requirement of the study.","reportingStatus":"POSTED","timeFrame":"At Baseline","title":"EHR COVID 19 Related Outcomes Baseline","type":"SECONDARY","unitOfMeasure":"Participants"}